SCHEMBL27444971

SCHEMBL27444971

CC(=O)COc1ccc(C(C)C(=O)OCc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.48
▸ MAOB P27338 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ ACACB O00763 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ PGR P06401 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ PTGS1 P23219 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ LTA4H P09960 1/20 0.45
▸ LAP3 P28838 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ PPARG P37231 1/20 0.45
▸ PPARA Q07869 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6792877 0.85 ALDH1A1 (0.58) ALDH1A1LMNAL3MBTL1PGRADORA3
SCHEMBL6792870 0.85 ALDH1A1 (0.58) ALDH1A1LMNAL3MBTL1PGRADORA3
SCHEMBL4007604 0.82 ALDH1A1 (0.58) ALDH1A1LMNAL3MBTL1PGRADORA3
SCHEMBL9234482 0.81 LMNA (0.56) ALDH1A1LMNAL3MBTL1PGRADORA3
SCHEMBL5182481 0.81 LMNA (0.56) ALDH1A1LMNAL3MBTL1PGRADORA3
SCHEMBL20425306 0.81 MAOB (0.70) ALOX5MAOBALDH1A1LMNAL3MBTL1
SCHEMBL7401422 0.81 LMNA (0.71) ALOX5MAOBALDH1A1ACACBLMNA
SCHEMBL27616913 0.80 MAOB (0.56) ALOX5MAOBACACBLMNAL3MBTL1
SCHEMBL6266373 0.79 LTA4H (0.59) ALOX5MAOBACACBLMNAL3MBTL1
SCHEMBL28968069 0.79 PSEN1 (0.52) ALDH1A1L3MBTL1PGRADORA3PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030911-B2 Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2024-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030911-B2 Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA RNASEH1, RNASE1, DNASE1 ALOX5 1258/4885MAOB 2570/4885ALDH1A1 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback